. 2015 Nov 2;139(1):144–160. doi: 10.1093/brain/awv319

Table 1.

Demographics and clinical details of the subjects

	Consistent micrographia group	Progressive micrographia group	Controls
Age, years^a (range)	60.39 ± 3.47 (54–67)	59.61 ± 3.34 (52–66)	59.94 ± 3.13 (55–65)
Sex^a	6 female, 12 male	5 female, 13 male	6 female, 12 male
Disease duration (years)^b	4.38 ± 1.31	4.09 ± 1.27
UPDRS motor score^b	20.39 ± 5.30	19.06 ± 4.78
Hoehn and Yahr staging^b	1.61 ± 0.40	1.53 ± 0.44
Fatigue Severity Scale^b	3.83 ± 0.96	3.98 ± 1.03
Mini-Mental State Examination^a	28.94 ± 1.11	29.28 ± 0.96	29.56 ± 0.70
l-DOPA dose (mg/day)^b	338.89 ± 69.78	305.56 ± 80.24

Values are (mean ± SD).

^aThe comparisons among the three groups were analysed with ANOVA (P > 0.05).

^bThe comparisons between the consistent micrographia and progressive micrographia group were analysed with two-sample t-tests (P > 0.05).